These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 5058095)
21. [Madecassol in the treatment of scleroderma (preliminary study)]. Szczepański A; Dabrowska H; Blaszczyk M Przegl Dermatol; 1974; 61(5):701-3. PubMed ID: 4419170 [No Abstract] [Full Text] [Related]
22. [Effect of combined treatment with nicotinic acid and DMSO on microcirculatory disorders in systemic scleroderma]. Aliab'eva AP; Mach ES; Balabanova RM Ter Arkh; 1978; 50(9):105-7. PubMed ID: 705639 [No Abstract] [Full Text] [Related]
23. [The course of scleroderma following treatment with carnitin]. Nitzschner H Dermatol Monatsschr; 1974 Jul; 160(7):592-6. PubMed ID: 4411133 [No Abstract] [Full Text] [Related]
24. [Scleroderma in children]. Beaudoing A; Bost M; Pont J; Dieterlen M Pediatrie; 1971; 26(5):529-46. PubMed ID: 5565710 [No Abstract] [Full Text] [Related]
25. [Morphological changes in the skin in scleroderma in the process of treatment with unithiol]. Dubinskiĭ AA; Tseraidis GS; Guĭda PP; Petrusenko EA; Babykina EA Vrach Delo; 1978 Oct; (10):112-4. PubMed ID: 716343 [No Abstract] [Full Text] [Related]
26. [Systemic sclerosis (scleroderma) without scleroderma]. Nadashkevych ON Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041 [TBL] [Abstract][Full Text] [Related]
27. [Madecassol treatment of systemic and localized scleroderma]. Guseva NG; Starovoĭtova MN; Mach ES Ter Arkh; 1998; 70(5):58-61. PubMed ID: 9644746 [TBL] [Abstract][Full Text] [Related]
30. [Use of Tebessal in scleroderma]. Mattos O; de Oliveira Neto MP Rev Bras Med; 1972 Mar; 29(3):139-40. PubMed ID: 5033154 [No Abstract] [Full Text] [Related]
31. [Therapeutic effectiveness of ultrasonics and lidase phonophoresis in various forms of scleroderma]. Didenko IG Vestn Dermatol Venerol; 1978 Jun; (6):76-9. PubMed ID: 354249 [No Abstract] [Full Text] [Related]
32. [Scleroderma and esophageal changes: treatment and instrumental control]. Altomare GF; Allara A; Pigatto PD G Ital Dermatol Venereol; 1984; 119(4):263-6. PubMed ID: 6490099 [No Abstract] [Full Text] [Related]
33. Dimethyl sulfoxide in scleroderma. Ehrlich GE; Joseph R Pa Med; 1965 Dec; 68(12):51-3. PubMed ID: 5856390 [No Abstract] [Full Text] [Related]
34. Scleroderma in children. Black CM Adv Exp Med Biol; 1999; 455():35-48. PubMed ID: 10599321 [No Abstract] [Full Text] [Related]
35. [Clinical aspects and course of schleroderma in children]. Khamaganova AV; Soiukov EA Vestn Dermatol Venerol; 1979 Nov; (11):38-41. PubMed ID: 525009 [No Abstract] [Full Text] [Related]
36. [Treatment of scleroderma and dermatomyositis in childhood]. Ansell BM Clin Ter; 1978 Jan; 84(2):123-31. PubMed ID: 648095 [No Abstract] [Full Text] [Related]
37. [Proteolytic enzyme, trypsin, in therapy of patients with scleroderma]. Dovzhanskiĭ SI; Slesarenko NA Vestn Dermatol Venerol; 1977 Aug; (8):56-8. PubMed ID: 930311 [No Abstract] [Full Text] [Related]
38. [About some effects of dimethyl sulfoxide (DMSO) in percutaneous use]. Kappert A Schweiz Med Wochenschr; 1968 Nov; 98(46):1829-37. PubMed ID: 5705674 [No Abstract] [Full Text] [Related]
39. Iloprost for scleroderma. Constans T; Diot E; Lasfargues G Ann Intern Med; 1991 Apr; 114(7):606. PubMed ID: 1705762 [No Abstract] [Full Text] [Related]